Commercialization: Page 26

PharmaVoice Team/PharmaVoice

Is Your eClinical System a Mixed Tape or a Playlist?

Just a decade ago, the most advanced option for listening to music at home was a large stereo system made up of a jumble of separate components, all with specific functions, from a half-dozen brands. Not only were these stereo systems bulky they were also expensive, complex to set up and run, onl...
By James Streeter • June 1, 2018
PharmaVoice Team/PharmaVoice

AI and the Cloud: Changing the Clinical Trial Experience

It doesn’t take a crystal ball to see that there are a number of exciting life-science industry trends that will profoundly influence clinical trial solutions in the years to come. Chief among them are: Patient engagement and patient centricity will be king, driving digital transformation with Io...
By Karim Damji • June 1, 2018
PharmaVoice Team/PharmaVoice

Pediatric Drug Development: Regulatory Updates to Know

All applications for marketing authorization for new medicines must include the results of studies in children as described in the pediatric plan, unless the medicine is exempt because of a deferral or waiver. Pediatric legislation internationally has led to better medicines for children, but gap...
By Dr. Martine Dehlinger-Kremer • June 1, 2018
PharmaVoice Team/PharmaVoice

Rare Disease Studies: Patient-Focused Approaches

The National Organization for Rare Disorders (NORD) indicates that there are approximately 7,000 medical conditions that qualify for a rare disease designation. In the United States, this is defined as an affected population with a prevalence of fewer than 200,000 patients. Because there is a gre...
By Bruce Smith • June 1, 2018
PharmaVoice Team/PharmaVoice

GoBoldly: A Reputation-Enhancing Effort

We’ve all seen the commercials. They feature patients living with serious diseases and the researchers working to develop innovative therapies. These ads focus on the science and the breakthroughs being made in medicine. They end with what looks like a genetic analysis giving way to the words Ame...
By Denise Myshko • June 1, 2018
PharmaVoice Team/PharmaVoice

Speak Out

Understanding The Why Applying health psychology to deliver effective patient support As a health and clinical psychologist, I’ve spent the last ten years helping the healthcare industry address the self-management needs of patients living with long-term conditions. For the most part, this work h...
By Kate Perry • June 1, 2018
PharmaVoice Team/PharmaVoice

Letter from the Editor

Riding the AI Wave It would be hard to identify a hotter trend right now than artificial intelligence and machine learning — a trend 60 years in the making since John McCarthy coined the term AI while leading a Dartmouth Summer Research Project. Merriam-Webster defines AI as: a branch of computer...
By Taren Grom • May 1, 2018
PharmaVoice Team/PharmaVoice

Marketing Integration

The pharmaceutical industry has been employing cross-functional teams to improve processes across business silos for quite sometime, but the ongoing shift in healthcare markets and the increasing complexity of drug commercialization has created an environment where cross-functional alignment has ...
By Robin Robinson • May 1, 2018
PharmaVoice Team/PharmaVoice

SHOWCASE: mHealth: The Power of mHealth in Transforming Health Delivery

Investment in mHealth is growing and in the first half of 2017 $3.5 billion was invested in 188 digital health companies. According to Juniper Research, the number of wearable devices will reach 130 million in 2018 at an estimated value of $19 billion. Its use has become widespread in medical set...
By PharmaVoice Team • May 1, 2018
PharmaVoice Team/PharmaVoice

Introducing BYOD 2.0: A More Inclusive Approach to Electronic Clinical Outcome Assessment

In its list of “Top 10 Strategic Trends for 2018," Gartner, Inc., notes that the digital and physical worlds are becoming more closely aligned. This phenomenon is certainly observable in clinical research, as technology is supporting more effective remote research through the use of electronic cl...
By Chris Watson • May 1, 2018
PharmaVoice Team/PharmaVoice

The Connection for Patients to mHealth and Modern Patient Empowerment

Our mobile-first, soon to be mobile-only world We live in a mobile-first world. The fact is nearly 7 in 10 Americans1 are using mobile devices every day and many of those are finding less relevance with “desktop" computing. There is something incredibly liberating in having a device with you all ...
By Chris Cullmann • May 1, 2018
PharmaVoice Team/PharmaVoice

Biotech Buzz

Venture capital funding trends indicate a healthy environment for biopharma companies. The recent five-year trend has been very good with more dollars being deployed into venture-backed companies, many of which are R&D focused; there is more money available to biopharma companies compared wit...
By Denise Myshko • May 1, 2018
PharmaVoice Team/PharmaVoice

New Players and Old Disrupting The Industry

Disruption has become the new normal for the healthcare and life-sciences industry. And while several companies — industry incumbents, such as payers and providers — have been pursuing strategies to transform the industry and create greater efficiencies, the dynamic changed with the entry of tech...
By Kim Ribbink • May 1, 2018
PharmaVoice Team/PharmaVoice

Speak Out

Synchronizing HCP and Consumer Messages: At The Point of Care and Beyond Mobile devices have transformed the way we experience the world – including how we wait for things to happen. Look around any doctor’s office waiting room, or the line at the pharmacy, or the treadmills at your local gym. Pe...
By Rick Morello • May 1, 2018
PharmaVoice Team/PharmaVoice

Letter from the Editor

Getting personal There’s a pretty good chance that everyone reading this special issue — Patients’ Voices — is either a patient, a caregiver to a patient, or knows someone who has been diagnosed with a chronic or acute condition. But just because we are all patients or know a patient doesn’t mean...
By Taren Grom • April 1, 2018
PharmaVoice Team/PharmaVoice

Upfront

Amicus Therapeutics Launches Healing Beyond Disease Amicus Therapeutics has launched Healing Beyond Disease, a global, employee-driven initiative inspired by people living with rare diseases and their families. Healing Beyond Disease is designed to enhance and expand the company’s support for pat...
By PharmaVoice Team • April 1, 2018
PharmaVoice Team/PharmaVoice

HealthTech

Patient-Centered Apps Trend Watch: Pharma Increases Consumer-Facing Apps and Digital Tools Pfizer Launches Novel Programs To Put Important Support Services At The Fingertips Of Cancer Patients Pfizer has developed enhanced offerings to help patients manage their life with cancer. Pfizer Oncology ...
By PharmaVoice Team • April 1, 2018
PharmaVoice Team/PharmaVoice

Last Word

Acquisition and Integration Jane Griffiths, Ph.D., Global Head of Actelion, discusses the process of integration post acquisition by Johnson & Johnson in November 2017. PV: Why did J&J acquire Actelion? Griffiths: J&J had spotted Actelion several years prior to the acquisition because...
By Jane Griffiths • April 1, 2018
PharmaVoice Team/PharmaVoice

Patients' Voices

PharmaVOICE editors have been writing about patient-centricity and all this topic encompasses for what seems like a decade. Some say the term has lost meaning because of its ubiquituous use. We contend that patients are leading the way and influencing how businesses operate today. For sure, there...
By PharmaVoice Team • April 1, 2018
PharmaVoice Team/PharmaVoice

Patient-Based Business Strategies

With patients taking center stage in discussions around new products, tools, and technologies, it’s not surprising to see so many companies moving the patient to the center of their operational business strategies, starting in the clinic all the way through to commercialization. Liz Lewis, chief ...
By Taren Grom • April 1, 2018
PharmaVoice Team/PharmaVoice

Patients and Health Literacy

What people know about health and healthcare and what they do with that knowledge has a major impact on their health and well-being. When patients are given health information in a way they can understand, they tend to make better health decisions. Low health literacy, on the other hand, is a con...
By Denise Myshko • April 1, 2018
PharmaVoice Team/PharmaVoice

Patient Journeys And Storytelling

Real life patient stories started seeping into the pharma lexicon well over a decade ago, on both a commercial and research level. The industry began turning to end users to discover how to create better drug delivery processes, clinical trial protocols, and marketing efforts, as well as to accur...
By Robin Robinson • April 1, 2018
PharmaVoice Team/PharmaVoice

Technology and Patient-Centric Trials

The term patient-centric is about ensuring the needs and perspectives of the patients are taken into consideration while maintaining scientific rigor for a clinical trial. Pharmaceutical sponsors have begun engaging patients in the trial design, seeking input and acknowledging the importance of t...
By PharmaVoice Team • April 1, 2018
PharmaVoice Team/PharmaVoice

The Changing Role of Patient Advocacy

The role of patient advocacy is a broad one — from supporter, to sponsor, to campaigner, to spokesperson and beyond. Indeed, patient advocacy means different things to different stakeholders, says Keri McDonough, senior team leader, Biosector 2, a Syneos Health company. “When patient advocacy gro...
By Kim Ribbink • April 1, 2018
PharmaVoice Team/PharmaVoice

Patient-Centered Apps

The pharmaceutical industry is up against several challenges when it comes to developing mobile apps for its consumers. According to Deloitte, issues of consumer trust, app design, and regulatory concerns can throw up roadblocks in the very crowded and competitive field of 300,000-plus healthcare...
By PharmaVoice Team • April 1, 2018